MedPeer,Inc. (TYO:6095)
Japan
· Delayed Price · Currency is JPY 449.00
+1.00 (0.22%)
Apr 24, 2025, 3:30 PM JST
MedPeer,Inc. Income Statement
Financials in millions JPY. Fiscal year is October - September.
Millions JPY. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2016 - 2019 |
| Revenue | 14,322 | 14,948 | 14,540 | 8,452 | 7,435 | 5,311 | Upgrade
|
| Revenue Growth (YoY) | -4.56% | 2.81% | 72.03% | 13.68% | 39.99% | 74.42% | Upgrade
|
| Cost of Revenue | 7,696 | 8,076 | 7,674 | 3,418 | 2,581 | 1,805 | Upgrade
|
| Gross Profit | 6,626 | 6,872 | 6,866 | 5,034 | 4,854 | 3,506 | Upgrade
|
| Selling, General & Admin | 5,059 | 5,333 | 5,423 | 3,892 | 2,987 | 2,332 | Upgrade
|
| Other Operating Expenses | -39 | -39 | 14 | 30 | 46 | 28 | Upgrade
|
| Operating Expenses | 5,306 | 5,580 | 5,746 | 3,970 | 3,070 | 2,401 | Upgrade
|
| Operating Income | 1,320 | 1,292 | 1,120 | 1,064 | 1,784 | 1,105 | Upgrade
|
| Interest Expense | -15 | -14 | -13 | -1 | -1 | -1 | Upgrade
|
| Earnings From Equity Investments | 56 | 55 | 57 | 46 | 34 | 37 | Upgrade
|
| Other Non Operating Income (Expenses) | -48 | -60 | -2 | 4 | -7 | -13 | Upgrade
|
| EBT Excluding Unusual Items | 1,313 | 1,273 | 1,162 | 1,113 | 1,810 | 1,128 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -117 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -7 | -11 | - | - | - | - | Upgrade
|
| Asset Writedown | -281 | -281 | - | - | - | - | Upgrade
|
| Other Unusual Items | 1,388 | 1,388 | - | - | - | - | Upgrade
|
| Pretax Income | 2,413 | 2,369 | 1,045 | 1,113 | 1,810 | 1,128 | Upgrade
|
| Income Tax Expense | 880 | 871 | 408 | 299 | 479 | 327 | Upgrade
|
| Earnings From Continuing Operations | 1,533 | 1,498 | 637 | 814 | 1,331 | 801 | Upgrade
|
| Minority Interest in Earnings | -13 | -17 | -20 | -2 | -38 | -76 | Upgrade
|
| Net Income | 1,520 | 1,481 | 617 | 812 | 1,293 | 725 | Upgrade
|
| Net Income to Common | 1,520 | 1,481 | 617 | 812 | 1,293 | 725 | Upgrade
|
| Net Income Growth | 138.99% | 140.03% | -24.02% | -37.20% | 78.34% | 84.01% | Upgrade
|
| Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 22 | 22 | 22 | 23 | 23 | 22 | Upgrade
|
| Shares Change (YoY) | -0.83% | -1.64% | -2.79% | -1.27% | 3.49% | 11.61% | Upgrade
|
| EPS (Basic) | 69.99 | 68.22 | 28.30 | 37.61 | 60.05 | 34.99 | Upgrade
|
| EPS (Diluted) | 69.99 | 68.22 | 27.99 | 35.78 | 56.25 | 32.67 | Upgrade
|
| EPS Growth | 140.81% | 143.73% | -21.77% | -36.39% | 72.18% | 64.75% | Upgrade
|
| Free Cash Flow | - | 1,676 | 561 | 774 | 1,249 | 878 | Upgrade
|
| Free Cash Flow Per Share | - | 77.20 | 25.42 | 34.09 | 54.31 | 39.51 | Upgrade
|
| Dividend Per Share | 4.500 | 4.500 | 4.500 | - | - | - | Upgrade
|
| Gross Margin | 46.26% | 45.97% | 47.22% | 59.56% | 65.29% | 66.01% | Upgrade
|
| Operating Margin | 9.22% | 8.64% | 7.70% | 12.59% | 24.00% | 20.81% | Upgrade
|
| Profit Margin | 10.61% | 9.91% | 4.24% | 9.61% | 17.39% | 13.65% | Upgrade
|
| Free Cash Flow Margin | - | 11.21% | 3.86% | 9.16% | 16.80% | 16.53% | Upgrade
|
| EBITDA | 1,898 | 1,916 | 1,930 | 1,249 | 1,952 | 1,245 | Upgrade
|
| EBITDA Margin | 13.25% | 12.82% | 13.27% | 14.78% | 26.25% | 23.44% | Upgrade
|
| D&A For EBITDA | 577.5 | 624 | 810 | 185 | 168 | 140 | Upgrade
|
| EBIT | 1,320 | 1,292 | 1,120 | 1,064 | 1,784 | 1,105 | Upgrade
|
| EBIT Margin | 9.22% | 8.64% | 7.70% | 12.59% | 24.00% | 20.81% | Upgrade
|
| Effective Tax Rate | 36.47% | 36.77% | 39.04% | 26.86% | 26.46% | 28.99% | Upgrade
|
| Advertising Expenses | - | 602 | 664 | 686 | 543 | 337 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.